参考文献[1]MurrowRW,SchweigerGD,KepesJJ,etal.Parkinsonismduetoabasalganglialacunarstate:clinicopathologiccorrelation[J].Neurology,1990,40(6):897-900.[2]LevinOS,ChimagomedovaAS,SkripkinaNA,etal.NonmotorSymptomsinVascularandOtherSecondaryParkinsonism.[J].InternationalReviewofNeurobiology,2017,134:1303-1334.[3]YamanouchiH,NaguraH.NeurologicalSignsandFrontalWhiteMatterLesionsinVascularParkinsonismAClinicopathologicStudy[J].Stroke;ajournalofcerebralcirculation,1997,28(5):965-9.[4]LiuW.VascularParkinsonism[J].CerebrovascularDiseasesForeignMedicalSciences,2004,333(5):513-524.[5]ManosalvaHA,PioF,JeerakathilT,etal.VascularParkinsonisminaTertiaryCareStrokePreventionClinicandtheDevelopmentofaNewScreeningStrategy.[J].JStrokeCerebrovascDis,2018,27:153-161.[6]GlassPG,LeesAJ,BacellarA,etal.Theclinicalfeaturesofpathologicallyconfirmedvascularparkinsonism.[J].JournalofNeurologyNeurosurgery&Psychiatry,2012,83(10):1027-9.[7]CaslakeR,TaylorK,ScottN,etal.Age-,andgender-specificincidenceofvascularparkinsonism,progressivesupranuclearpalsy,andparkinsonian-typemultiplesystematrophyinNorthEastScotland:thePINEstudy[J].Parkinsonism&RelatedDisorders,2014,20(8):834-839.[8]中华医学会神经病学分会帕金森病及运动障碍学组.中国血管性帕金森综合征诊断与治疗专家共识[J].全科医学临床与教育,2017,50(4):364-367.[9]ZijlmansJC,DanielSE,HughesAJ,etal.Clinicopathologicalinvestigationofvascularparkinsonism,includingclinicalcriteriafordiagnosis.[J].MovementDisorders,2004,19(6):630–640.[10]KrackP,DowseyPL,BenabidAL,etal.Ineffectivesubthalamicnucleusstimulationinlevodopa-resistantpostischemicparkinsonism.[J].Neurology,2000,54(11):2182-4.[11]户村则昭,玉川芳春,加藤敏郎,Vascularparkinsonismのcomputedtomography所见脑と神经,1985,370)：1007~1012.[12]HughesAJ,DanielSE,KilfordL,etal.AccuracyofclinicaldiagnosisofidiopathicParkinson'sdisease:aclinico-pathologicalstudyof100cases.[J].JournalofNeurologyNeurosurgery&Psychiatry,1992,55(3):181.[13]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):701-708.[14]陆再英,钟南山.内科学.第7版[M].人民卫生出版社,2008.[15]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中国实用乡村医生杂志,2012,19(18):390-419.[16]张祥建,范振增,张丽英.脑出血诊疗指南[J].中国全科医学,2004,7(18):1319-1320.[17]颜红兵,柯元南.美国冠心病诊断与治疗指南[J].2004.[18]LuJ,LiD,LiF,etal.MontrealcognitiveassessmentindetectingcognitiveimpairmentinChineseelderlyindividuals:apopulation-basedstudy.[J].JournalofGeriatricPsychiatry&Neurology,2011,24(4):184.[19]国家职业分类大典和职业资格工作委员会.中华人民共和国职业分类大典[M].中国劳动社会保障出版社,1999.[20]ZijlmansJC,DanielSE,HughesAJ,etal.Clinicopathologicalinvestigationofvascularparkinsonism,includingclinicalcriteriafordiagnosis[J].MovementDisorders,2004,19(6):630–640.[21]中华医学会神经病学分会帕金森病及运动障碍学组.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271.[22]苏立静,徐俊,马甲.血管性帕金森综合征56例临床分析[J].现代实用医学,2016,28(4):448-450.[23]BenamerHTS,GrossetDG.VascularParkinsonism:AClinicalReview[J].EuropeanNeurology,2009,61(1):11-15.[24]BenítezriveroS,PalomarFJ,MartínrodríguezJF,etal.Abnormalsensorimotorintegrationcorrelateswithcognitiveprofileinvascularparkinsonism.[J].JournaloftheNeurologicalSciences,2017,377:161–166.[25]甘蓉,张玉虎,聂坤,等.α突触核蛋白基因多态性与帕金森病及其认知障碍的相关性研究[J].中华老年心脑血管病杂志,2012,14(8):788-791.[26]PsychCCJM,JanPetterLarsenMDPhD,DagAarslandMDPhD,etal.Subtypesofmildcognitiveimpairmentinparkinson'sdisease:Progressiontodementia[J].MovementDisorders,2006,21(9):1343-1349.[27]SollingerAB,GoldsteinFC,LahJJ,etal.MildcognitiveimpairmentinParkinson’sdisease:Subtypesandmotorcharacteristics[J].Parkinsonism&RelatedDisorders,2010,16(3):177.[28]ColosimoC,MorganteL,AntoniniA,etal.Non-motorsymptomsinatypicalandsecondaryparkinsonism:thePRIAMOstudy.[J].JournalofNeurology,2010,257(1):5-14.[29]HoylesK,SharmaJC.OlfactorylossasasupportingfeatureinthediagnosisofParkinson’sdisease:apragmaticapproach[J].JournalofNeurology,2013,260(12):2951-2958.[30]Navarro-OtanoJ,GaigC,MuxiA,etal.123I-MIBGcardiacuptake,smellidentificationand123I-FP-CITSPECTinthedifferentialdiagnosisbetweenvascularparkinsonismandParkinson'sdisease[J].Parkinsonism&RelatedDisorders,2014,20(2):192-7[31]袁晶,王含,万新华.帕金森病相关认知功能障碍[J].中国现代神经疾病杂志,2017,17(6).[32]郭丽花,胡如英,龚巍巍,等.脑卒中危险因素研究进展[J].中国老年学,2017,37(17).[33]赵德强.血管性帕金森综合征与帕金森病临床特点及影像学的对比研究[J].南方医科大学学报,2005,25(7):868-870.[34]GasserT.MendelianformsofParkinson'sdisease[J].BiochimicaEtBiophysicaActa,2009,1792(7):587-596.[35]FoltynieT,BrayneC,BarkerRA.TheheterogeneityofidiopathicParkinson'sdisease.[J].JournalofNeurology,2002,249(2):138-45.[36]万志荣,商梦晴,冯涛,等.早发型与晚发型帕金森病患者临床异质性的研究[J].临床神经病学杂志,2016,29(3):178-181.[37]FrigerioR,ElbazA,SanftK.R,等.帕金森病之前的受教育水平和职业:一项人群病例对照研究[J].世界核心医学期刊文摘:神经病学分册,2006(3):36-37.[38]乔晋,屈秋民,韩建峰,等.西安地区老年人帕金森病患病率调查[J].中国神经免疫学和神经病学杂志,2001,8(2):79-83.[39]齐江彤,查曹兵,陈伟良,等.血管性帕金森综合征与帕金森病的临床特点与影像学特征比较[J].武警医学,2015,26(6):545-547.[40]杨娉婷,袁洪,王雅琴,等.高血压前期体检人群血管内皮功能及其与脉搏波传导速度的关系[J].中国动脉硬化杂志,2014,22(5):472-476.[41]ChamorroA.Roleofinflammationinstrokeandatherothrombosis[J].CerebrovascularDiseases,2004,17Suppl3(1):1.[42]孙刚顺.血管性帕金森综合征相关因素分析[J].中国老年保健医学,2011,09(2):52-53.[43]谈世东.血管性帕金森综合征临床研究进展[J].国际神经病学神经外科学杂志,2010,37(2):131-135.[44]李敏,钱阔,范博,等.成人2型糖尿病微血管病变与血清25-羟维生素D相关性探讨[J].糖尿病新世界,2017,20(12):44-45.[45]王新,李春阳,苏立平,等.动脉粥样硬化发病机制及治疗的研究进展[J].实用心脑肺血管病杂志,2017,25(2):1-4.[46]DuXL,EdelsteinD,DimmelerS,etal.HyperglycemiainhibitsendothelialnitricoxidesynthaseactivitybyposttranslationalmodificationattheAktsite.[J].JournalofClinicalInvestigation,2001,108(9):1341.[47]MorigiM,AngiolettiS,ImbertiB,etal.Leukocyte-endothelialinteractionisaugmentedbyhighglucoseconcentrationsandhyperglycemiainaNF-kB-dependentfashion.[J].JournalofClinicalInvestigation,1998,101(9):1905-1915.[48]高升.糖尿病并发脑卒中的临床分析及防治[J].中外医学研究,2015(10):105-106.[49]HanChengWangMD,ShihJungChengMD.Thesyndromeofacutebilateralbasalganglialesionsindiabeticuremicpatients[J].JournalofNeurology,2003,250(8):948.[50]NelsonCP,HambySE,DanishS,etal.GeneticallyDeterminedHeightandCoronaryArteryDisease—NEJM[J].NewEnglandJournalofMedicine,2015,372(17):1608-18.[51]谢诗情,程文静,祝骥,等.动脉粥样硬化机制的研究进展[J].世界复合医学,2016,2(3):85-90.[52]BarabashS,NorbergO.Strawberryextractpresentsantiplateletactivitybyinhibitionofinflammatorymediatorofatherosclerosis(sP-selectin,sCD40L,RANTES,andIL-1β)andthrombusformation[J].Platelets,2015,26(3):224-229.[53]SadowskiM,ZbczykM,UndasA.Coronarythrombuscomposition:Linkswithinflammation,plateletandendothelialmarkers[J].Atherosclerosis,2014(237):555-561.[54]魏岗之.血管性帕金森综合征临床病理报告[J].中华神经科杂志,2004,43(7):473-474.[55]ValeTC,CaramelliP,CardosoF．Clinicoradiologicalcomparisonbe-tweenvascularparkinsonismandParkinson’sdisease［J］．JNeurolNeurosurgPsychiatry,2014,86(5):547-553．[56]WrightCB,PaikMC,BrownTR,etal.TotalHomocysteineIsAssociatedWithWhiteMatterHyperintensityVolumeTheNorthernManhattanStudy[J].Stroke;ajournalofcerebralcirculation,2005,36(6):1207-11.[57]HaraK,OndaK,OuchiH,etal.[Acaseofvascularparkinsonismassociatedwithhyperhomocysteinemiaandmethylenetetrahydrofolatereductasegenevariant(C677T)][J].Rinshoshinkeigaku=Clinicalneurology,2016,56(2):77.[58]金超,曹中朝.动脉粥样硬化相关因素研究进展[J].现代临床医学,2016,42(3):166-169.[59]SteinbergD.Atherogenesisinperspective:hypercholesterolemiaandinflammationaspartnersincrime.[J].NatureMedicine,2002,8(11):1211.[60]张填,陈志斌,王埮,等.Cys-C在急性脑梗死并发SIRS致MODS患者中的水平变化[J].中风与神经疾病,2014,31(8):713-715.
版权保护: 本文由 hbsrm.com编辑，转载请保留链接: www.hbsrm.com/ysl/byzy/247.html
